Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Blairs, The FDA has not approved the combination therapy for general use. We are now in stage II. You would expect the testing sites to get the word out to potential patients.

Our sample size is still too small to be clinically significant hence the need to complete the start of phase II and 19 additional patients.